The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients
1 other identifier
interventional
120
1 country
2
Brief Summary
The purpose of this study is to evaluate whether the proposed cognitive-behavioural intervention is effective for DSH patients in the age group 15-35 years. In addition, we will examine which elements derived from the theoretical model can explain the efficacy of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Mar 2002
Longer than P75 for phase_2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFebruary 1, 2006
January 1, 2005
September 13, 2005
January 31, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
repetition of DSH
Secondary Outcomes (1)
psychiatric diagnosis, depression, hopelessness, suicidal intent, suicidal cognitions, self-concept, (cognitive) coping, emotion regulation difficulties, impulsivity, social support, hostility, personality disorder related beliefs and attachment style.
Interventions
Eligibility Criteria
You may qualify if:
- DSH patients will be included if they recently have been engaged in an act of DSH including overdoses of medication, ingestion of chemical substances and self-inflicted injuries according to the definition which is used in the WHO/Euro Multicentre Study on parasuicide: "An act with non-fatal outcome in which an individual deliberately initiates a non-habitual behaviour, that without intervention from others will cause self-harm, or deliberately ingests a substance in excess of the prescribed or generally recognised dosage, and which is aimed at realising changes that the person desires via the actual or expected physical consequences" (Platt et al., 1992). In addition, only DSH patients aged 15-35 will be included.
You may not qualify if:
- DSH patients with severe psychiatric disorders requiring intensive long-term psychiatric treatment, such as schizophrenia, will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Leiden University Medical Center
Leiden, Netherlands
MCH Westeinde
The Hague, Netherlands
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Philip Spinhoven, prof. dr.
Leiden University, department of clinical psychology
- STUDY DIRECTOR
Nadia Garnefski, dr.
Leiden University department of clinical psychology
- PRINCIPAL INVESTIGATOR
Nadja Slee, MSc
Leiden University department of clinical psychology
- STUDY DIRECTOR
Ella Arensman, dr.
National Suicide Research Foundation, Cork
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 15, 2005
Study Start
March 1, 2002
Study Completion
March 1, 2007
Last Updated
February 1, 2006
Record last verified: 2005-01